Doug Murphy Chutorian
About Doug Murphy Chutorian
Chief Executive Officer Doug Murphy-Chutorian
Doug Murphy-Chutorian currently serves as the Chief Executive Officer. With a diverse career spanning various sectors, he brings extensive leadership experience to his role. His stewardship has been integral in navigating the complexities of regulatory approval processes for numerous products across different industries, including medical devices, health services, pharmaceuticals, and biotechnology.
Doug Murphy-Chutorian Education and Medical Training
Doug Murphy-Chutorian received both his B.A. and M.D. from Columbia University. He proceeded to complete his internal medicine residency at the New York University/Bellevue Medical Center. Further specializing in cardiology, he completed his fellowship at the Stanford University Medical Center. This comprehensive educational background has been foundational in his career in interventional cardiology and leadership roles.
Doug Murphy-Chutorian Medical and Healthcare Expertise
Doug Murphy-Chutorian's expertise in the medical field includes interventional cardiology. He has served as a faculty member at both Stanford and Montefiore Medical Centers. His experience extends beyond clinical practice to managing directorial roles in various healthcare organizations. His expertise is broad, covering medical devices, health services, pharmaceuticals, biotechnology, and managed care.
Doug Murphy-Chutorian Innovation and Patents
Doug Murphy-Chutorian is a named inventor on more than 30 patents. His contributions to innovation span various medical and healthcare technologies. These patents underscore his commitment to advancing the field through technological developments and groundbreaking medical solutions.
Doug Murphy-Chutorian Career in Healthcare Investment
From 2005 to 2012, Doug Murphy-Chutorian served as the managing director of Select Healthcare Capital, LLC. In this capacity, he was involved in guiding over 50 products through regulatory approval processes. This role allowed him to leverage his medical and business expertise to drive investment and development in healthcare technologies.